Annual report
3747.TEDINET S100PVAV
Period2021-10-01 → 2022-09-30
Filed2022-12-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 143
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.1bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥2.2bn | 2020-10-01 → 2021-09-30 | Cons. | Net sales |
| Revenue | ¥2.2bn | 2019-10-01 → 2020-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.8bn | 2018-10-01 → 2019-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.9bn | 2017-10-01 → 2018-09-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥241m | 2021-10-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥219m | 2020-10-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥63m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥22m | 2020-10-01 → 2021-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥84m | 2019-10-01 → 2020-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥412m | 2018-10-01 → 2019-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥335m | 2017-10-01 → 2018-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥217m | 2021-10-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥247m | 2020-10-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥174m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥202m | 2020-10-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥51m | 2019-10-01 → 2020-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥408m | 2018-10-01 → 2019-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥338m | 2017-10-01 → 2018-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥179m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥206m | 2020-10-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥1.6bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥1.5bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥1.4bn | at 2020-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.2bn | at 2019-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.5bn | at 2018-09-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥315m | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥337m | at 2021-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥1.3bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥910m | at 2020-09-30d | Cons. | Net assets |
| Net assets / equity | ¥755m | at 2019-09-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥1.1bn | at 2018-09-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥857m | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥609m | at 2021-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥857m | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥609m | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥527m | at 2020-09-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥693m | at 2019-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥831m | at 2018-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥270m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥221m | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥308m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥433m | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥246m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥11m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥29m | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥21m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥47m | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥40m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥10m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥111m | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥263m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥248m | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥60m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥24.15 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.05 | 2020-10-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.05 | 2019-10-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-56.78 | 2018-10-01 → 2019-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-47.04 | 2017-10-01 → 2018-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥178.49 | at 2022-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥154.34 | at 2021-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥126.29 | at 2020-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥101.54 | at 2019-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥147.87 | at 2018-09-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 79.7% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.4% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.9% | at 2020-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 59.4% | at 2019-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.4% | at 2018-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 14.5% | 2021-10-01 → 2022-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 20.0% | 2020-10-01 → 2021-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.2% | 2019-10-01 → 2020-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | -45.5% | 2018-10-01 → 2019-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | -27.4% | 2017-10-01 → 2018-09-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 87 | at 2022-09-30 | Cons. | Number of employees |
| Employees | 90 | at 2021-09-30 | Cons. | Number of employees |
| Employees | 89 | at 2020-09-30d | Cons. | Number of employees |
| Employees | 113 | at 2019-09-30d | Cons. | Number of employees |
| Employees | 110 | at 2018-09-30d | Cons. | Number of employees |
| Revenue | ¥2.0bn | 2021-10-01 → 2022-09-30 | Standalone | Net sales |
| Revenue | ¥2.1bn | 2020-10-01 → 2021-09-30 | Standalone | Net sales |
| Revenue | ¥2.1bn | 2019-10-01 → 2020-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.6bn | 2018-10-01 → 2019-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.7bn | 2017-10-01 → 2018-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥220m | 2021-10-01 → 2022-09-30 | Standalone | Operating income |
| Operating income | ¥230m | 2020-10-01 → 2021-09-30 | Standalone | Operating income |
| Ordinary income | ¥221m | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥230m | 2020-10-01 → 2021-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥102m | 2019-10-01 → 2020-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥360m | 2018-10-01 → 2019-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥302m | 2017-10-01 → 2018-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥230m | 2021-10-01 → 2022-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥229m | 2020-10-01 → 2021-09-30 | Standalone | Income before income taxes |
| Net income | ¥201m | 2021-10-01 → 2022-09-30 | Standalone | Profit loss |
| Net income | ¥190m | 2020-10-01 → 2021-09-30 | Standalone | Profit loss |
| Net income | ¥63m | 2019-10-01 → 2020-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | −¥347m | 2018-10-01 → 2019-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | −¥333m | 2017-10-01 → 2018-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.4bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥1.3bn | at 2021-09-30 | Standalone | Assets |
| Total assets | ¥1.3bn | at 2020-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.1bn | at 2019-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥1.4bn | at 2018-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥300m | at 2022-09-30 | Standalone | Liabilities |
| Total liabilities | ¥330m | at 2021-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥1.1bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥947m | at 2021-09-30 | Standalone | Net assets |
| Net assets / equity | ¥757m | at 2020-09-30d | Standalone | Net assets |
| Net assets / equity | ¥694m | at 2019-09-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.0bn | at 2018-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥803m | at 2022-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥559m | at 2021-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥27.94 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.5 | 2020-10-01 → 2021-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.76 | 2019-10-01 → 2020-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-48.28 | 2018-10-01 → 2019-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-46.41 | 2017-10-01 → 2018-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥159.77 | at 2022-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥131.83 | at 2021-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥105.33 | at 2020-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥96.57 | at 2019-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥144.85 | at 2018-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 79.2% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.2% | at 2021-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.4% | at 2020-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.1% | at 2019-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.1% | at 2018-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 19.2% | 2021-10-01 → 2022-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.4% | 2020-10-01 → 2021-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2019-10-01 → 2020-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -40.0% | 2018-10-01 → 2019-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -27.6% | 2017-10-01 → 2018-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 7,444,800 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,444,800 | at 2021-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,444,800 | at 2020-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,444,800 | at 2019-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,444,800 | at 2018-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 80 | at 2022-09-30 | Standalone | Number of employees |
| Employees | 83 | at 2021-09-30 | Standalone | Number of employees |
| Employees | 78 | at 2020-09-30d | Standalone | Number of employees |
| Employees | 98 | at 2019-09-30d | Standalone | Number of employees |
| Employees | 95 | at 2018-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 61
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-09-30 | −¥67,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-09-30 | −¥67,000 |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-09-30 | −¥291m |
| Business Solutionreportable segment | capex | 2021-10-01 → 2022-09-30 | ¥136,000 |
| Business Solutionreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥420,000 |
| Business Solutionreportable segment | employees | at 2022-09-30 | 18 pure |
| Business Solutionreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥278m |
| Business Solutionreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥278m |
| Business Solutionreportable segment | segment assets | at 2022-09-30 | ¥78m |
| Business Solutionreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥22m |
| Financial Solution Service Divisionreportable segment | capex | 2021-10-01 → 2022-09-30 | ¥17m |
| Financial Solution Service Divisionreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥30m |
| Financial Solution Service Divisionreportable segment | employees | at 2022-09-30 | 53 pure |
| Financial Solution Service Divisionreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥1.6bn |
| Financial Solution Service Divisionreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥1.6bn |
| Financial Solution Service Divisionreportable segment | segment assets | at 2022-09-30 | ¥1.5bn |
| Financial Solution Service Divisionreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥561m |
| Health Care Business Divisionreportable segment | employees | at 2022-09-30 | 4 pure |
| Health Care Business Divisionreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥132m |
| Health Care Business Divisionreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥132m |
| Health Care Business Divisionreportable segment | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥67,000 |
| Health Care Business Divisionreportable segment | segment assets | at 2022-09-30 | ¥52m |
| Health Care Business Divisionreportable segment | segment profit | 2021-10-01 → 2022-09-30 | −¥52m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-10-01 → 2022-09-30 | ¥17m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-10-01 → 2022-09-30 | ¥30m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-10-01 → 2022-09-30 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-10-01 → 2022-09-30 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-10-01 → 2022-09-30 | ¥67,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-09-30 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-10-01 → 2022-09-30 | ¥532m |
| Reconciling Itemsreconciling | revenue | 2020-10-01 → 2021-09-30 | −¥75,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2020-10-01 → 2021-09-30 | −¥75,000 |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-09-30 | −¥305m |
| Business Solutionreportable segment | capex | 2020-10-01 → 2021-09-30 | ¥158,000 |
| Business Solutionreportable segment | depreciation | 2020-10-01 → 2021-09-30 | ¥476,000 |
| Business Solutionreportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥267m |
| Business Solutionreportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥267m |
| Business Solutionreportable segment | segment assets | at 2021-09-30 | ¥82m |
| Business Solutionreportable segment | segment profit | 2020-10-01 → 2021-09-30 | ¥12m |
| Financial Solution Service Divisionreportable segment | capex | 2020-10-01 → 2021-09-30 | ¥41m |
| Financial Solution Service Divisionreportable segment | depreciation | 2020-10-01 → 2021-09-30 | ¥25m |
| Financial Solution Service Divisionreportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥1.8bn |
| Financial Solution Service Divisionreportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥1.8bn |
| Financial Solution Service Divisionreportable segment | segment assets | at 2021-09-30 | ¥1.3bn |
| Financial Solution Service Divisionreportable segment | segment profit | 2020-10-01 → 2021-09-30 | ¥597m |
| Health Care Business Divisionreportable segment | depreciation | 2020-10-01 → 2021-09-30 | ¥436,000 |
| Health Care Business Divisionreportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥131m |
| Health Care Business Divisionreportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥131m |
| Health Care Business Divisionreportable segment | revenue intersegment | 2020-10-01 → 2021-09-30 | ¥75,000 |
| Health Care Business Divisionreportable segment | segment assets | at 2021-09-30 | ¥57m |
| Health Care Business Divisionreportable segment | segment profit | 2020-10-01 → 2021-09-30 | −¥84m |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-10-01 → 2021-09-30 | ¥41m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-10-01 → 2021-09-30 | ¥26m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-10-01 → 2021-09-30 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-10-01 → 2021-09-30 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-10-01 → 2021-09-30 | ¥75,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-09-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-10-01 → 2021-09-30 | ¥525m |
| Business Solutionreportable segment | employees | at 2022-09-30 | 12 pure |
| Financial Solution Service Divisionreportable segment | employees | at 2022-09-30 | 53 pure |
| Health Care Business Divisionreportable segment | employees | at 2022-09-30 | 3 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,214
| Item | Context | Value | Unit |
|---|---|---|---|
| Total return on share price index | Prior1YearInstant_NonConsolidatedMember | 1.329 | |
| Total return on share price index | CurrentYearInstant_NonConsolidatedMember | 1.234 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E05424-000FinancialSolutionServiceDivisionReportableSegmentsMember | 53 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E05424-000BusinessSolutionReportableSegmentsMember | 18 | |
| Number of employees | CurrentYearInstant_jpcrp030000-asr_E05424-000HealthCareBusinessDivisionReportableSegmentsMember | 4 | |
| Number of employees | CurrentYearInstant_CorporateSharedMember | 12 | |
| Number of employees | CurrentYearInstant | 87 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 80 | |
| Average age years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 40 | |
| Average age months information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 5 | |
| Average length of service years information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 11 | |
| Average length of service months information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 0 | |
| Average annual salary information about reporting company information about employees | CurrentYearInstant_NonConsolidatedMember | 5405000 | JPY |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05424-000FinancialSolutionServiceDivisionReportableSegmentsMember | 53 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05424-000BusinessSolutionReportableSegmentsMember | 12 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E05424-000HealthCareBusinessDivisionReportableSegmentsMember | 3 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember_CorporateSharedMember | 12 | |
| Number of employees | CurrentYearInstant_NonConsolidatedMember | 80 | |
| Research and development expenses research and development activities | CurrentYearDuration | 46000000 | JPY |
| Capital expenditures overview of capital expenditures etc | CurrentYearDuration | 12000000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 7444800 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 7444800 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 7444800 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 7444800 | |
| Number of shares constituting one unit | CurrentYearInstant_OrdinaryShareMember | 100 | |
| Number of shareholders national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shareholders financial institutions | CurrentYearInstant_OrdinaryShareMember | 2 | |
| Number of shareholders financial service providers | CurrentYearInstant_OrdinaryShareMember | 19 | |
| Number of shareholders other corporations | CurrentYearInstant_OrdinaryShareMember | 21 | |
| Number of shareholders foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 20 | |
| Number of shareholders foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 13 | |
| Number of shareholders individuals and others | CurrentYearInstant_OrdinaryShareMember | 3252 | |
| Number of shareholders total | CurrentYearInstant_OrdinaryShareMember | 3327 | |
| Number of shares held number of units national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Number of shares held number of units financial institutions | CurrentYearInstant_OrdinaryShareMember | 1318 | |
| Number of shares held number of units financial service providers | CurrentYearInstant_OrdinaryShareMember | 11061 | |
| Number of shares held number of units other corporations | CurrentYearInstant_OrdinaryShareMember | 9811 | |
| Number of shares held number of units foreign investors other than individuals | CurrentYearInstant_OrdinaryShareMember | 1189 | |
| Number of shares held number of units foreign individual investors | CurrentYearInstant_OrdinaryShareMember | 199 | |
| Number of shares held number of units individuals and others | CurrentYearInstant_OrdinaryShareMember | 50850 | |
| Number of shares held number of units total | CurrentYearInstant_OrdinaryShareMember | 74428 | |
| Number of shares held shares less than one unit | CurrentYearInstant_OrdinaryShareMember | 2000 | |
| Percentage of shareholdings national and local governments | CurrentYearInstant_OrdinaryShareMember | － | |
| Percentage of shareholdings financial institutions | CurrentYearInstant_OrdinaryShareMember | 0.0177 | |
| Percentage of shareholdings financial service providers | CurrentYearInstant_OrdinaryShareMember | 0.1486 | |
| Percentage of shareholdings other corporations | CurrentYearInstant_OrdinaryShareMember | 0.1318 | |
| Percentage of shareholdings foreigners other than individuals | CurrentYearInstant_OrdinaryShareMember | 0.0160 | |
| Percentage of shareholdings foreign individuals | CurrentYearInstant_OrdinaryShareMember | 0.0027 | |
| Percentage of shareholdings individuals and others | CurrentYearInstant_OrdinaryShareMember | 0.6832 | |
| Number of shares held | CurrentYearInstant_No1MajorShareholdersMember | 1346400 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |